--- html/Profile-antiinfectives1.htm	2001/02/22 20:51:23	1.1
+++ html/Profile-antiinfectives1.htm	2001/03/02 09:43:21	1.2
@@ -10,7 +10,7 @@
   strains of bacteria. The program is currently keeping pace with its ambitious 
   plans and efforts are being focused on fine-tuning the derivatization process 
   in order to enter the development phase within the next year.</p>
-<p align="center"><img src="p/OKrnd_ljudi_7.jpg" width="300" height="202"></p>
+<p align="center"><img src="p/OKrnd_ljudi_7.jpg" width="300" height="202" border=1></p>
 <p>The goal of PLIVA's second program is to find a novel anti-bacterial compound 
   class showing no cross-resistance with current antibiotics. In cooperation with 
   Althexis, Boston, USA, a company with leading expertise in structure-based drug